Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C Source: Eur Respir J 2005; 26: Suppl. 49, 84s Year: 2005
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
The prevalence rate of chronic hepatitis B and C among pulmonary TB patients Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease Source: Eur Respir J 2005; 25: 570-573 Year: 2005
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy Source: Eur Respir J 2009; 33: 1518-1519 Year: 2009
Successful hepatitis B treatment with lamivudine and interferon-alpha in a patient with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Sarcoidosis related to interferon and ribavirin treatment of hepatitis C – Analysis of four cases Source: International Congress 2014 – Sarcoidosis Year: 2014
Prevalence of hepatitis c virus infection among patients with COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009
Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
The incidence of hepatitis C virus in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006
Fulminant hepatitis during antituberculosis chemotherapy: five case reports Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 13s Year: 2006
Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006
Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014